InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Encrantz Staffan, Director. Insider active across 1 companies, notably Sight Sciences, Inc.. Aggregated, 7 reports have been recorded. Total volume traded: €24.6m. The latest transaction was filed on 13 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
€13,8561,802 shares@ €7.68920.0051% mcap0.1% of flow
Common Stock
SEC:0000899243-22-018500:0·
Ideal exit: 7 Feb 2023 (T+270)
€1m84,254 shares@ €16.68260.52% mcap11.4% of flow
Common Stock
SEC:0000899243-21-046456·
Ideal exit: 26 Aug 2022 (T+270)
€1m84,254 shares@ €16.68260.52% mcap5.7% of flow
Common Stock
SEC:0000899243-21-046456:0·
Ideal exit: 26 Aug 2022 (T+270)
€11m527,048 shares@ €20.6654.02% mcap88.6% of flow
Common Stock
SEC:0000899243-21-040878·
Ideal exit: 15 Jul 2022 (T+270)
€11m527,048 shares@ €20.6654.02% mcap44.3% of flow
Common Stock
SEC:0000899243-21-040878:0·
Ideal exit: 15 Jul 2022 (T+270)
02,970,070 shares0
Common Stock
SEC:0000899243-21-028879·
02,970,070 shares0
Common Stock
SEC:0000899243-21-028879:0·
7 of 7 declarations
About Encrantz Staffan
Staffan Encrantz is a Director at Sight Sciences, Inc. As a board member, he participates in overseeing the company's activities and making strategic decisions. Encrantz brings valuable insight through his experience in the healthcare sector, thereby contributing to the governance and direction of the company.
